Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth-quarter 2025 investor letter. A ...
Over the course of a year, U.S. President Donald Trump’s administration has become the most disruptive force in global trade since the 1930s. But the destruction of the post–Cold War trade order—a ...
As 2026 unfolds, familiar investment risks are resurfacing, but with sharper edges. Interest rate expectations, AI’s evolving influence, and increasingly ...
Microsoft promises to replenish water and pay for energy consumed by its new data centers Upcoming data centers will be 'Community-First', it promises Backlash to environmentally damaging data centers ...
Koi security researchers found that when NPM installs a dependency from a Git repository, configuration files such as a malicious ‘.npmrc’ can override the git binary path, leading to full code ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...
Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...
This week’s cybersecurity recap highlights key attacks, zero-days, and patches to keep you informed and secure.
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that ...
Keep tabs on Texas politics and policy with our morning newsletter. The Texas Tribune Independent news. Trusted by Texans. About The Texas Tribune | Staff | Contact | Send a Confidential Tip | Ethics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results